Literature DB >> 22182742

Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of exposure to stress and modulation by mecamylamine.

Pravinkumar Bhutada1, Yogita Mundhada, Yogesh Ghodki, Pankaj Dixit, Sudhir Umathe, Kishor Jain.   

Abstract

Nicotinic acetylcholine receptors mediate some of the rewarding and motivational effects of ethanol, including relapses. Relapses are common in drug addicts during abstinence when exposure to any stressor ensues. However, the role of nicotinic acetylcholine receptors in the ethanol- and stress-induced reinstatement of ethanol-induced conditioned place preference has not yet been explored. Therefore, the present study investigated the influence of mecamylamine, a nicotinic acetylcholine receptors antagonist on acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in adult male Swiss mice. The results revealed that mecamylamine (0.1-10 µg/mouse, intracerebroventricularly) dose dependently prevented the development, expression, and reinstatement of ethanol-induced conditioned place preference. Further, acute treatment with mecamylamine blocked the restraint stress and forced swim stress-induced reinstatement of ethanol-induced conditioned place preference. All of these treatments had no influence on the locomotor activity. Therefore, it is concluded that mecamylamine blocks the acquisition, expression and reinstatement of conditioned reinforcing effects of ethanol without per se reinforcing or aversive influence. This ability of mecamylamine might be a potential advantage in the treatment of alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22182742     DOI: 10.1177/0269881111431749

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  18 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

Review 2.  Modeling relapse in animals.

Authors:  Rémi Martin-Fardon; Friedbert Weiss
Journal:  Curr Top Behav Neurosci       Date:  2013

3.  Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization.

Authors:  Noah R Gubner; Carrie S McKinnon; Tamara J Phillips
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

4.  Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers.

Authors:  Daniel J O Roche; Lara A Ray; Megan M Yardley; Andrea C King
Journal:  Curr Addict Rep       Date:  2016-02-03

5.  Nicotine enhances the locomotor stimulating but not the conditioned rewarding effect of ethanol in DBA/2J mice.

Authors:  Noah R Gubner; Christopher L Cunningham; Tamara J Phillips
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

Review 6.  The role of nicotinic acetylcholine receptors in alcohol-related behaviors.

Authors:  C N Miller; H M Kamens
Journal:  Brain Res Bull       Date:  2020-07-22       Impact factor: 4.077

7.  Mammalian target of rapamycin complex 1 and its downstream effector collapsin response mediator protein-2 drive reinstatement of alcohol reward seeking.

Authors:  Sami Ben Hamida; Sophie Laguesse; Nadege Morisot; Jong-Hyun Park; Khanhky Phuamluong; Anthony L Berger; Ki Duk Park; Dorit Ron
Journal:  Addict Biol       Date:  2018-07-18       Impact factor: 4.280

Review 8.  Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence.

Authors:  Jie Wu; Ming Gao; Devin H Taylor
Journal:  Acta Pharmacol Sin       Date:  2014-01-27       Impact factor: 6.150

Review 9.  How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use?

Authors:  Sherry A McKee; Andrea H Weinberger
Journal:  Annu Rev Clin Psychol       Date:  2012-11-13       Impact factor: 18.561

Review 10.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.